Hsin-Fu Lee

Jan 1, 2025 | mdpi.com | Hsin-Fu Lee

1. IntroductionOver the past few decades, endovascular revascularization has emerged as a cornerstone therapy, providing a minimally invasive alternative to traditional surgical bypass in patients with peripheral artery disease (PAD). This approach has gained traction due to its ability to restore perfusion while reducing procedural morbidity and hospital stays, particularly in high-risk populations such as elderly patients and those with multiple comorbidities [1,2].

Apr 16, 2024 | medrxiv.org | Jo-Nan Liao |Yi-Hsin Chan |Hsin-Fu Lee |Yung-Hsin Yeh

The authors have declared no competing interest. This study was supported by grants 105-2628-B-182A-003-MY3 from the Ministry of Science and Technology (MOST 110-2314-B-075-059, MOST 111-2314-B-075-004-MY2) and grants CMRPG3E1681, CMRPG3E1682, CMRPG3E1683, and CORPG3G0351 from Chang Gung Memorial Hospital, Linkou, Taiwan. I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.